A Randomised Phase II Trial of Palbociclib and Fulvestrant Vs Standard Endocrine Therapy in Patients with ER Positive HER2 Negative Breast Cancer and Ctdna Detected Molecular Relapse During Adjuvant Endocrine Therapy (TRAK-ER)
CANCER RESEARCH(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要